- ►asnjournals.org MR Weir - Clinical Journal of the American Society of Nephrology, 2007 - Am Soc Nephrol To reduce the burden of cardiovascular disease (CVD), management strategies are
increasingly focusing on preventive measures following early detection of
markers of atherosclerosis. This review focuses on microalbuminuria, which ... Cited by 47 - Related articles - BL Direct - All 3 versions
- ►rug.nl [PDF] J Atthobari, FW Asselbergs, C Boersma, R de … - Clinical therapeutics, 2006 - Elsevier PREVEND IT was a single-center, double-blind, randomized, placebo-controlled
trial with a 2 × 2 factorial design within the larger observational Prevention
of REnal and Vascular ENdstage Disease (PREVEND) study. The PREVEND IT ... Cited by 20 - Related articles - All 6 versions
P Ferrari - Nephrology, 2007 - interscience.wiley.com SUMMARY: In Australia the number of patients developing end-stage kidney disease
is growing. Almost 70% of new cases of treated end-stage kidney disease are due
to diabetes, hypertension or glomerulonephritis. The majority of these ... Cited by 18 - Related articles - BL Direct - All 4 versions
BG Jaar, R Khatib, L Plantinga, LE Boulware … - Clinical Journal of the American Society of Nephrology, 2008 - Am Soc Nephrol The goal of a medical screening program is to recognize a disease in its
preclinical phase so that intervention can occur at earlier stages, hopefully
leading to better outcomes. Screening programs may also promote public ... Cited by 13 - Related articles - All 3 versions
AJ Palmer, L Annemans, S Roze, P Lapuerta, … - Kidney International, 2005 - nature.com A peer-reviewed, published Markov model that simulated progression from
microalbuminuria to nephropathy, doubling of serum creatinine, ESRD, and
all-cause mortality in patients with hypertension, type 2 diabetes, and ... Cited by 14 - Related articles - All 3 versions
I Codreanu, N Perico, SK Sharma, A … - Nephrology, 2006 - interscience.wiley.com SUMMARY: Development of strategies for the early detection and prevention of
non-communicable diseases, including kidney disease, is the only realistic
strategy to avert an imminent global health and economic crisis and enhance ... Cited by 11 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] AH Anis, H Sun, S Singh, J Woolcott, B Nosyk … - Pharmacoeconomics, 2006 - ingentaconnect.com Introduction: The LIFE (Losartan Intervention For Endpoint reduction in hyper-
Abstract tension) study demonstrated a 13% relative risk reduction in the
primary compos- ite endpoint (myocardial infarction, stroke or death) for ... Cited by 11 - Related articles - BL Direct - All 9 versions
AJ Palmer, WJ Valentine, R Chen, N Mehin, … - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA Background. Nephropathy is an indicator of end-organ damage and is a strong
predictor of an increased risk of cardiovascular disease and death in patients
with diabetes. Screening can lead to early identification and treatment, ... Cited by 7 - Related articles - BL Direct - All 6 versions
AJ Palmer, R Chen, WJ Valentine, S Roze, B … - Diabetes and Metabolism, 2006 - Elsevier A Markov/Monte Carlo model simulated lifetime impacts of screening for
albuminuria (microalbuminuria/overt nephropathy) using semi-quantitative urine
dipsticks in a primary care setting, and subsequent addition of irbesartan ... Cited by 9 - Related articles - BL Direct - All 3 versions
AJ Palmer, WJ Valentine, DMD Tucker, JA Ray … - Current Medical Research and Opinion®, 2006 - informahealthcare.com Andrew J. palmer a, William J. Valentine a, daniel M. d. tucker a, Joshua A. ray
a, stéphane roze a, lieven Annemans b,c, pablo lapuerta d, roland Chen d,
sylvie Gabriel e, paulo Carita e, roger A. rodby f, dick de Zeeuw g, ... Cited by 8 - Related articles - BL Direct - All 6 versions
